Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MAXCIE M SIKORA

Allopathic & Osteopathic Physicians Allergy & Immunology

NPI
1982886826
CMS profile
316612
Location
DESTIN, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$2,012.76

108 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,012.76 108

By paying entity

PY2021 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 108 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MAXCIE M SIKORA

NPI 1982886826 · CMS profile ID 316612

Allopathic & Osteopathic Physicians / Allergy & Immunology

DESTIN, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 108 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1982886826?year=2021&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MAXCIE M SIKORA, NPI 1982886826, CMS profile ID 316612. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 108 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1982886826?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). MAXCIE M SIKORA, NPI 1982886826, CMS profile ID 316612. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 108 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1982886826?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
MAXCIE M SIKORA, NPI 1982886826, CMS profile ID 316612, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 108 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1982886826?year=2021&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

108 matching records · $2,012.76 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 108 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 108.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Optinose US, Inc. $20.1307/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 851672863 CMS
AstraZeneca Pharmaceuticals LP $12.6507/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829338999 CMS
GlaxoSmithKline, LLC. $9.9507/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802332801 CMS
GlaxoSmithKline, LLC. $0.9907/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802868229 CMS
GlaxoSmithKline, LLC. $13.0907/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802980765 CMS
AstraZeneca Pharmaceuticals LP $12.4707/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829518097 CMS
AstraZeneca Pharmaceuticals LP $15.8007/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829756533 CMS
Genentech USA, Inc. $12.7207/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835949235 CMS
GENZYME CORPORATION $22.2406/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843589499 CMS
GlaxoSmithKline, LLC. $16.2806/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 803009117 CMS
Optinose US, Inc. $23.7806/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 851672865 CMS
kaleo, Inc. $11.4006/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832127521 CMS
AstraZeneca Pharmaceuticals LP $12.2106/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830106761 CMS
GlaxoSmithKline, LLC. $11.6206/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802680169 CMS
GlaxoSmithKline, LLC. $25.6006/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802313739 CMS
PFIZER INC. $23.5406/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833282959 CMS
Optinose US, Inc. $3.8405/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 851672837 CMS
Genentech USA, Inc. $15.9505/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835949231 CMS
Teva Pharmaceuticals USA, Inc. $22.9705/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839707543 CMS
Optinose US, Inc. $17.3605/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 851672839 CMS
Takeda Pharmaceuticals U.S.A., Inc. $27.3905/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 820253485 CMS
GlaxoSmithKline, LLC. $17.5705/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 801707955 CMS
Teva Pharmaceuticals USA, Inc. $11.4305/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839707541 CMS
GlaxoSmithKline, LLC. $25.9905/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 803169763 CMS
GlaxoSmithKline, LLC. $12.4205/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802491293 CMS
GlaxoSmithKline, LLC. $17.3505/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 803089115 CMS
Genentech USA, Inc. $17.9704/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835949229 CMS
Optinose US, Inc. $3.2804/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 851672791 CMS
GlaxoSmithKline, LLC. $15.2104/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802671981 CMS
GlaxoSmithKline, LLC. $26.1104/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802851691 CMS
Optinose US, Inc. $16.4304/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 851672793 CMS
PFIZER INC. $9.3604/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833397591 CMS
GlaxoSmithKline, LLC. $21.6504/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802223147 CMS
AstraZeneca Pharmaceuticals LP $14.8204/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829456957 CMS
GlaxoSmithKline, LLC. $24.7704/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802345117 CMS
GlaxoSmithKline, LLC. $29.8103/31/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 801966837 CMS
Eyevance Pharmaceuticals LLC $14.4903/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 807280473 CMS
GlaxoSmithKline, LLC. $15.5803/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 801704879 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.9703/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763345054 CMS
Genentech USA, Inc. $19.9803/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835949225 CMS
Optinose US, Inc. $17.1802/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 851672775 CMS
PFIZER INC. $18.6402/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833282765 CMS
PFIZER INC. $2.1502/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833396819 CMS
GlaxoSmithKline, LLC. $19.0302/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802246229 CMS
GlaxoSmithKline, LLC. $16.4702/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802602565 CMS
AstraZeneca Pharmaceuticals LP $13.1802/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829746089 CMS
Teva Pharmaceuticals USA, Inc. $11.1802/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839707539 CMS
GlaxoSmithKline, LLC. $26.8502/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 802697029 CMS
Genentech USA, Inc. $16.3402/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835949223 CMS
Regeneron Healthcare Solutions, Inc. $21.0202/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 809625317 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $5,824.35 130
PY2020 $6,671.85 141
PY2021 $2,012.76 108
PY2022 $1,907.14 97
PY2023 $999.77 46
PY2024 $1,804.19 76
PY2025 $5,933.75 108

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $131,372.42 11
PY2024 Principal investigator $94,533.10 11
PY2023 Principal investigator $14,111.63 4
PY2022 Principal investigator $77,553.54 7
PY2021 Principal investigator $112,744.61 12
PY2020 Principal investigator $116,957.88 24
PY2019 Principal investigator $100,437.77 27

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

11 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 SANOFI US SERVICES INC. $550.00 12/02/2025 Non-covered Recipient Entity
Clinical Research Center Of Alabama LLC
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Longterm Safety of Dupilumab in Children 2 to <6 Years of Age With Uncontrolled Asthma and/or Recurrent Severe Asthmatic Wheeze No dispute reported 06/30/2026 1226136486
Principal investigator 1 SANOFI US SERVICES INC. $500.00 12/02/2025 Non-covered Recipient Entity
Clinical Research Center Of Alabama LLC
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Longterm Safety of Dupilumab in Children 2 to <6 Years of Age With Uncontrolled Asthma and/or Recurrent Severe Asthmatic Wheeze No dispute reported 06/30/2026 1226136490
Principal investigator 1 Novartis Pharmaceuticals Corporation $54,844.32 10/08/2025 Non-covered Recipient Entity
ALLERVIE HEALTH DESTIN
A US Phase 3b, Multi-center, Randomized, Double-blind, Double-Dummy Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-Antihista No dispute reported 06/30/2026 1190301669
Principal investigator 1 SANOFI US SERVICES INC. $600.00 05/12/2025 Non-covered Recipient Entity
Clinical Research Center Of Alabama LLC
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Longterm Safety of Dupilumab in Children 2 to <6 Years of Age With Uncontrolled Asthma and/or Recurrent Severe Asthmatic Wheeze No dispute reported 06/30/2026 1226136248
Principal investigator 1 SANOFI US SERVICES INC. $4,719.50 05/12/2025 Non-covered Recipient Entity
Clinical Research Center Of Alabama LLC
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Longterm Safety of Dupilumab in Children 2 to <6 Years of Age With Uncontrolled Asthma and/or Recurrent Severe Asthmatic Wheeze No dispute reported 06/30/2026 1226136253
Principal investigator 1 SANOFI US SERVICES INC. $4,404.60 05/12/2025 Non-covered Recipient Entity
Clinical Research Center Of Alabama LLC
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Longterm Safety of Dupilumab in Children 2 to <6 Years of Age With Uncontrolled Asthma and/or Recurrent Severe Asthmatic Wheeze No dispute reported 06/30/2026 1226136257
Principal investigator 1 SANOFI US SERVICES INC. $500.00 05/12/2025 Non-covered Recipient Entity
Clinical Research Center Of Alabama LLC
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Longterm Safety of Dupilumab in Children 2 to <6 Years of Age With Uncontrolled Asthma and/or Recurrent Severe Asthmatic Wheeze No dispute reported 06/30/2026 1226136260
Principal investigator 1 Eli Lilly and Company $11,750.00 03/27/2025 Non-covered Recipient Entity
CLINICAL RESEARCH CTR OF ALABAMA, LLC
A LONG-TERM STUDY TO ASSESS THE SAFETY AND EFFICACY OF LEBRIKIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS No dispute reported 06/30/2026 1187878429
Principal investigator 1 SANOFI US SERVICES INC. $500.00 03/04/2025 Non-covered Recipient Entity
Clinical Research Center Of Alabama LLC
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Longterm Safety of Dupilumab in Children 2 to <6 Years of Age With Uncontrolled Asthma and/or Recurrent Severe Asthmatic Wheeze No dispute reported 06/30/2026 1226136160
Principal investigator 1 AstraZeneca UK Limited $31,719.50 01/29/2025 Non-covered Recipient Entity
CLINICAL RESEARCH CENTER OF ALABAMA
a randomized,double blind,multicenter,parallel group,phase IIIb 52 week study evaluating the efficacy and safety of PT027 compared with PT007 administered as needed in participants 12 to under 18 years of age with asthma ACADIA No dispute reported 06/30/2026 1185546623
Principal investigator 1 AstraZeneca Pharmaceuticals LP $21,284.50 01/13/2025 Non-covered Recipient Entity
ALLERVIE HEALTH
The CHRONICLE Study is a multi center,non interventional,prospective cohort study of adults with severe asthma who do not achieve control with high-dose ICS therapy with additional controllers and or require systemic corticosteroid or monoclonal antibod No dispute reported 06/30/2026 1185546621